Business Standard

Dip in demand for Covid medicines takes a toll on drug sales in March

Covid related drugs contributed 40% of the pharma market last year

ANTIVIRAL REMDESIVIR, DRUGS, covid, coronavirus
Premium

Another reason for the dip in volume sales could be inventory calibration ahead of the 10 per cent price rise in essential drugs.

Sohini Das Mumbai
The dip in demand for Covid-19 drugs, which roughly contributed to 40 per cent of the Indian pharmaceutical market (IPM) during the pandemic period, has dragged down the overall growth of the domestic drug market in March. The IPM recorded a two per cent decline in value growth and a 9.4 per cent decline in sales volumes in March, according to Awacs data.

Monthly sales in March were Rs 12,932 crore, showed the data. The strong demand for drugs in March 2021, when India was going through the second wave of Covid infections, has led to a high base effect

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in